rs143185010
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS1
The NM_001365999.1(SZT2):c.5377G>A(p.Glu1793Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000133 in 1,604,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. E1793E) has been classified as Likely benign.
Frequency
Consequence
NM_001365999.1 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 18Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
- genetic developmental and epileptic encephalopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152168Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000208 AC: 50AN: 240226 AF XY: 0.000231 show subpopulations
GnomAD4 exome AF: 0.000137 AC: 199AN: 1452608Hom.: 0 Cov.: 32 AF XY: 0.000156 AC XY: 113AN XY: 722202 show subpopulations
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152286Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74460 show subpopulations
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:2
- -
- -
- -
- -
Inborn genetic diseases Uncertain:1
The c.5206G>A (p.E1736K) alteration is located in exon 36 (coding exon 36) of the SZT2 gene. This alteration results from a G to A substitution at nucleotide position 5206, causing the glutamic acid (E) at amino acid position 1736 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at